GE to Invest in Israeli Company That Developed Swallowable Endoscopic Capsules

Share on Facebook
General Electric Healthcare plans to invest in Check-Cap, an Israeli company developing swallowable endoscopic capsules for imaging inside the GI tract, through its $250 million healthymagination fund, according to a news release.

The capsule differs from competitor Given Imaging's PillCam because it uses low-energy X-rays instead of light. This produces a different image and could eliminate the need for typical GI tract preparation because X-rays penetrate through soft material like food. The technology could be used to screen for colorectal cancer as well as other diseases of the GI tract.

Check-Cap plans to introduce the technology in Europe before the end of 2013 and is currently in talks with the FDA.

Related Articles on Gastroenterology:
Colorectal Cancer Screening Rates by the Numbers: 12 Recent Statistics
Study: Demand for Screening Colonoscopy Down During Recession
Global Endoscopy Market Expected to Grow 13.2% in Next Three Years

© Copyright ASC COMMUNICATIONS 2014. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

New From Becker's GI & Endoscopy

Regional Gastroenterology Associates of Lancaster names director of clinical services

Read Now

Upcoming Events